![Pharmaceuticals policy / Drugs / Clinical pharmacology / Food and Drug Administration / David Hager / Emergency contraception / Over-the-counter drug / Contraception / Prescription medication / Medicine / Health / Pharmacology Pharmaceuticals policy / Drugs / Clinical pharmacology / Food and Drug Administration / David Hager / Emergency contraception / Over-the-counter drug / Contraception / Prescription medication / Medicine / Health / Pharmacology](https://www.pdfsearch.io/img/edac0e3a58b8b378771c493e6cb710b1.jpg) Date: 2005-05-12 18:05:59Pharmaceuticals policy Drugs Clinical pharmacology Food and Drug Administration David Hager Emergency contraception Over-the-counter drug Contraception Prescription medication Medicine Health Pharmacology | | News Reports About FDA Advisor Raise New Questions About Agency’s Refusal to Approve Over-the-Counter Plan B Statement by Kirsten Moore, President of Reproductive Health Technologies Project For immediate release May 1Add to Reading ListSource URL: www.rhtp.orgDownload Document from Source Website File Size: 104,30 KBShare Document on Facebook
|